No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Recalcitrant pain in a patient with ADPKD

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

Volume 83, Issue 3, Pages (March 2013)

Shining light on vitamin D trials in chronic kidney disease

Kidney transplantation in a low-resource setting: Nigeria experience

Volume 61, Issue 2, Pages (February 2002)

Reassessment of the care of the patient with chronic kidney disease

John P. Middleton, Patrick H. Pun Kidney International

Volume 77, Issue 1, Pages 6-8 (January 2010)

Burden of chronic kidney disease: North Africa

Francesco Paolo Schena Kidney International

Jeffrey C. Fink, Glenn M. Chertow Kidney International

End-stage renal disease in living kidney donors

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Volume 80, Issue 9, Pages (November 2011)

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Volume 64, Issue 1, Pages (July 2003)

Volume 70, Issue 11, Pages (December 2006)

Gary C.W. Chan, Sydney C.W. Tang Kidney International

Volume 87, Issue 4, Pages (April 2015)

Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.

Volume 64, Issue 4, Pages (October 2003)

The analysis of survival data: the Kaplan–Meier method

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Nephrology Crossword: History of nephrology

Volume 76, Issue 5, Pages (September 2009)

Fructose intake as a risk factor for kidney stone disease

Response to ‘Hepcidin levels in patients with renal disease’

Volume 73, Issue 12, Pages (June 2008)

Volume 76, Issue 6, Pages (September 2009)

Yijian Huang, Rebecca Zhang, Steven D. Culler, Nancy G. Kutner

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Elevated risk of stroke among patients with end-stage renal disease

Alternate-day dialysis may be needed for hemodialysis patients

Volume 87, Issue 1, Pages (January 2015)

Racial disparities in access to transplantation: a tough nut to crack

Volume 76, Issue 8, Pages (October 2009)

Atrial fibrillation in end-stage renal disease: an emerging problem

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

Volume 80, Issue 6, Pages (September 2011)

Lynda Anne Szczech, Ira L. Lazar Kidney International

Volume 74, Issue 5, Pages (September 2008)

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Unilateral renal cystic disease

Volume 81, Issue 9, Pages (May 2012)

A man with a hole in his penis

Prehypertension: is it relevant for nephrologists?

Volume 73, Issue 9, Pages (May 2008)

Carmine Zoccali, Francesca Mallamaci Kidney International

Low triiodothyronine and survival in end-stage renal disease

The Iranian model of living renal transplantation

The Danish Renal Biopsy Register

Volume 80, Issue 10, Pages (November 2011)

Is complement a target for therapy in renal disease?

Volume 70, Issue 5, Pages (September 2006)

Volume 75, Issue 7, Pages (April 2009)

James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon

Volume 70, Issue 10, Pages (November 2006)

Volume 88, Issue 5, Pages (November 2015)

A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan Yi-Chun.

Stephen Pastan, J. Michael Soucie, William M. McClellan

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani, Franklin W. Maddux Kidney International Volume 84, Issue 3, Pages 555-561 (September 2013) DOI: 10.1038/ki.2013.152 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 1 Crude thrombosis and bleeding rate in end-stage renal disease (ESRD) patients initiated on subcutaneous enoxaparin or heparin for thromboprophylaxis. Unadjusted rates with 95% confidence intervals were calculated using Poisson regression. pt, patient. Kidney International 2013 84, 555-561DOI: (10.1038/ki.2013.152) Copyright © 2013 International Society of Nephrology Terms and Conditions